Which medication class is used cautiously to address severe behavioral symptoms in dementia?

Which medication class is used cautiously to address severe behavioral symptoms in dementia?

• A. Antipsychotics
• B. Antidepressants
• C. Anxiolytics
• D. Mood Stabilizers

Answer: (B)

Addressing severe behavioral symptoms in dementia requires careful weighing of benefits and risks, since older adults are especially vulnerable to medication-related harm. The medication class that warrants cautious use in this context is antipsychotics. They can help reduce agitation, aggression, or psychotic-like symptoms, but they carry significant risks for people with dementia, including higher mortality, cerebrovascular events, pneumonia, sedation, and falls. Because of these dangers, antipsychotics should be started only after nonpharmacologic strategies have been tried, used at the lowest effective dose, and limited to the shortest possible duration with ongoing re-evaluation. Monitor closely for extrapyramidal symptoms, metabolic issues, QT prolongation, and sedation, and reassess regularly to determine if continuing the medication is truly beneficial. Antidepressants may be considered when there is a coexisting mood disorder or anxiety contributing to behavioral symptoms, but they are not the primary treatment for severe BPSD. They carry their own risks (such as hyponatremia, drug interactions, and sedation) and the evidence for reliably reducing agitation is less robust than for antipsychotics in this specific context.

Addressing severe behavioral symptoms in dementia requires careful weighing of benefits and risks, since older adults are especially vulnerable to medication-related harm. The medication class that warrants cautious use in this context is antipsychotics. They can help reduce agitation, aggression, or psychotic-like symptoms, but they carry significant risks for people with dementia, including higher mortality, cerebrovascular events, pneumonia, sedation, and falls. Because of these dangers, antipsychotics should be started only after nonpharmacologic strategies have been tried, used at the lowest effective dose, and limited to the shortest possible duration with ongoing re-evaluation. Monitor closely for extrapyramidal symptoms, metabolic issues, QT prolongation, and sedation, and reassess regularly to determine if continuing the medication is truly beneficial.

Antidepressants may be considered when there is a coexisting mood disorder or anxiety contributing to behavioral symptoms, but they are not the primary treatment for severe BPSD. They carry their own risks (such as hyponatremia, drug interactions, and sedation) and the evidence for reliably reducing agitation is less robust than for antipsychotics in this specific context.